Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus
Phase 1
Recruiting
- Conditions
- Type 2 DiabetesOverweight or Obesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-04-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Carmot Australia First Pty Ltd
- Target Recruit Count
- 94
- Registration Number
- NCT05814107
- Locations
- 🇦🇺
Nucleus Network Pty Ltd., Melbourne, Australia
🇲🇽Avant Santé Research Center S.A. de C.V., San Pedro Garza García, Mexico
News
No news found